Since the DNA methylation status of MDA-MB-453 at the ABCA7 exon 5–intron 5 boundary more closely resembled that of triple-negative than that of Her2-positive breast cancer cell lines, we suggest classifying MDA-MB-453 as triple-negative. Here, ERBB2 is linked to breast carcinoma.